Dr. Padda Explains the Current Role of Immunotherapy in EGFR-Mutant Lung Cancer
Sukhmani Padda, MD, discusses the role of immunotherapy in patients with <em>EGFR</em>-positive non–small cell lung cancer.
Exploring Advantages to Third-Generation TKIs in Lung Cancer
Sukhmani Padda, MD, discusses how third-generation tyrosine kinase inhibitors compare to the first- and second-generation TKIs.
2 Commerce Drive Cranbury, NJ 08512